公开(公告)号：US11992023B2

公开(公告)日：2024-05-28

申请号：US17266392

申请日：2019-08-06

Applicant: Chr. Hansen A/S

Inventor： Jean-Marie Odinot ,  Emilien Langevin ,  Luciana Jimenez ,  Kasui Tang ,  Vera Kuzina Poulsen ,  Elahe Ghanei Moghadam ,  Gunnar Oeregaard

IPC: A23C9/123 ,  A23C9/133 ,  A23C9/137 ,  A23C9/142 ,  A23C19/076

CPC classification number: A23C9/1236 ,  A23C9/1234 ,  A23C9/133 ,  A23C9/137 ,  A23C9/1422 ,  A23C19/076 ,  A23V2400/137 ,  A23V2400/231 ,  A23V2400/249 ,  A23V2400/31

Abstract: The present invention relates to a process for producing a fermented milk soft cheese product including the steps of a) Providing a first milk base, b) Optionally subjecting the first milk base to a concentration step to obtain a concentrated first milk base, c) Adding a first starter culture including at least one EPS producing lactic acid bacterium strain, d) Fermenting the concentrated first milk base for a period of time until a target pH is reached to obtain an EPS-containing fermented milk composition, e) Mixing the EPS-containing fermented milk composition with one or more other ingredients, if any, selected from the group consisting of a milk fat composition, a second fermented milk composition and one or more additives, to obtain a fermented milk mixture, and f) Subjecting the fermented milk mixture to heat treatment to obtain a fermented milk soft cheese product.

公开(公告)号：US20240166989A1

公开(公告)日：2024-05-23

申请号：US18260850

申请日：2022-01-06

Applicant: Chr. Hansen A/S

Inventor： Thomas Janzen ,  Ditte Christiansen ,  Jesper Broend ,  Victoria Prebner ,  Ilenia Manuguerra ,  Geoffrey Ras

IPC: C12N1/20 ,  A23C9/123 ,  A23C11/10 ,  C12N9/12 ,  C12R1/225 ,  C12R1/46

CPC classification number: C12N1/205 ,  A23C9/1238 ,  A23C11/10 ,  A23C11/106 ,  C12N9/12 ,  C12N9/1205 ,  C12Y207/01006 ,  C12Y207/13003 ,  A23V2400/123 ,  A23V2400/249 ,  C12R2001/225 ,  C12R2001/46

Abstract: The present invention relates to a novel Streptococcus thermophilus strain having improved texturizing properties, compositions comprising said strain as well as fermented products manufactured using said strain.

公开(公告)号：US20230301317A1

公开(公告)日：2023-09-28

申请号：US18187811

申请日：2023-03-22

Applicant: Chr. Hansen A/S

Inventor： Solvej Siedler ,  Susanne Bidstrup ,  Rute Neves

IPC: A23C9/127 ,  A01N63/22 ,  A01P3/00

CPC classification number: A23C9/127 ,  A01N63/22 ,  A01P3/00

Abstract: The present invention provides a method of controlling growth of yeasts, in particular robust yeasts, by applying Bacillus substilis. More specifically, the present invention provides uses of Bacillus substilis to inhibit or delay growth of yeast like Yarrowia lipolytica by reducing the free iron concentration in a food product which is preferably a fermented food product. Preferably the Bacillus substilis is applied at a concentration of 104 to 109 CFU/ml, preferably 106 to 108 CFU/ml, most preferably 107 CFU/ml.

公开(公告)号：US20230292780A1

公开(公告)日：2023-09-21

申请号：US17919032

申请日：2021-04-16

Applicant: Chr. Hansen A/S

Inventor： Lieke VAN GIJTENBEEK ,  Solvej SIEDLER ,  Helle Skov GULDAGER ,  Louise Essendrup STEFFENSEN

IPC: A23C19/097 ,  A23C19/076 ,  C12N1/20

CPC classification number: A23C19/097 ,  A23C19/076 ,  C12N1/205 ,  A23Y2220/73 ,  C12R2001/225

Abstract: The present invention is in the field of food technology. The present invention provides methods of controlling growth of Listeria by limiting their access to manganese More specifically, the present invention provides a method of inhibiting or delaying growth of Listeria by reducing the manganese concentration in a food product which is preferably a dairy product. The invention also provides manganese scavengers and uses thereof to inhibit or delay Listeria growth.

公开(公告)号：US11758914B2

公开(公告)日：2023-09-19

申请号：US18145411

申请日：2022-12-22

Applicant: Chr. Hansen A/S

Inventor： Jeorgos Trihaas ,  Thomas Janzen ,  Patrick Derkx

IPC: C12N1/20 ,  A23C9/123 ,  C12N7/00 ,  C12N15/01 ,  C12R1/46

CPC classification number: A23C9/1238 ,  C12N1/20 ,  C12N1/205 ,  C12N7/00 ,  C12N15/01 ,  A23C2220/202 ,  C12N2795/00031 ,  C12R2001/46

Abstract: The present invention is directed to a method of producing a Streptococcus thermophilus strain comprising the steps of

a) Providing a mother strain in the form of Streptococcus thermophilus DSM32502,
b) Growing a culture of the mother strain in the presence of a bacteriophage, to which the mother strain is not resistant, to obtain a number of mutant strains, which are resistant to the said bacteriophage,
c) Measuring the acidification time of the bacteriophage-resistant mutant strains and the mother strain in a milk base and selecting at least one mutant strain with a reduced acidification time as compared to the mother strain to obtain a fast-acidifying mutant strain.

公开(公告)号：US20230235307A1

公开(公告)日：2023-07-27

申请号：US17986618

申请日：2022-11-14

Applicant: Chr. Hansen A/S

Inventor： Hans Raj ,  Pernille Smith ,  Thomas Eckhardt ,  Vojislav Vojinovic ,  Charlotte Elisabeth Grüner Schöller ,  Johannes Maarten van den Brink

IPC: C12N9/38 ,  A23L29/00

CPC classification number: C12N9/2471 ,  A23L29/06

Abstract: The present invention relates to new improved peptide or dimeric peptides exhibiting betagalactosidase enzyme activity as well as improved methods for reducing the lactose content in compositions, such as dairy products.

公开(公告)号：US20230227507A1

公开(公告)日：2023-07-20

申请号：US18008797

申请日：2021-06-10

Applicant: Chr. Hansen A/S

Inventor： Thomas Janzen ,  Ditte Ellegaard Christiansen ,  Mia Vissing Mikkelsen ,  Thomas Eckhardt

IPC: C07K14/315 ,  A23C19/032 ,  C12N1/20

CPC classification number: C07K14/315 ,  A23C19/0323 ,  C12N1/205 ,  A23Y2240/41 ,  C12R2001/46

Abstract: The present invention provides a method of increasing nisin production in nisin-producing Lactococcus lactis by inactivating the phage infection protein Pip. The invention also provides nisin-producing Lactococcus lactis in which the phage infection protein is inactivated. The nisin-producing Lactococcus lactis can be used in starter culture for manufacturing food products or other industrial applications.

公开(公告)号：US20230210121A1

公开(公告)日：2023-07-06

申请号：US16604134

申请日：2018-04-11

Applicant: Chr. Hansen A/S

Inventor： Hans RAJ ,  Pernille SMITH ,  Thomas ECKHARDT ,  Vojislav VOJINOVIC ,  Charlotte Elisabeth Grüner SCHÖLLER ,  Johannes Maarten VAN DEN BRINK

IPC: A23C9/12 ,  C12N9/38

CPC classification number: A23C9/1206 ,  C12N9/2471

Abstract: The present invention relates to new improved peptide or dimeric peptides exhibiting beta- galactosidase enzyme activity as well as improved methods for reducing the lactose content in compositions in particular at low temperatures.

公开(公告)号：US20230200406A1

公开(公告)日：2023-06-29

申请号：US17927131

申请日：2021-05-31

Applicant: Chr. Hansen A/S ,  Compagnie Gervais Danone

Inventor： Benoit Colson ,  Sonja Bloch ,  Gaelle Lettier Buchhorn ,  Nanna Christensen ,  Marie-Agnès Soucé ,  Laurent Marchal ,  Anne Depierris ,  Fanny Larrere

IPC: A23C9/123 ,  C12N1/20 ,  C12N15/10 ,  C12N9/12

CPC classification number: A23C9/1238 ,  C12N1/205 ,  C12N15/1034 ,  C12N9/1205 ,  C12R2001/46

Abstract: The invention relates to a composition for producing a fermented milk product comprising: (i) a starter culture comprising a glucose-fermenting Streptococcus thermophilus (St) strain and a glucose-fermenting Lactobacillus delbrueckii subsp. bulgaricus (Lb) strain; and (ii) a glucose-deficient Streptococcus thermophilus (St) strain, wherein said St strain is galactose-fermenting and carries a mutation in the DNA sequence of the glcK gene encoding a glucokinase protein, which mutation inactivates the glucokinase protein or has a negative effect on expression of the gene.

公开(公告)号：US11653689B2

公开(公告)日：2023-05-23

申请号：US17051653

申请日：2019-05-01

Applicant: Chr. Hansen A/S

Inventor： Brynjulf Mortensen ,  Anders Damholt ,  Anja Wellejus ,  Vibeke Westphal Stennicke ,  Johan E. T. Van Hycklama Vlieg

IPC: A23L33/135 ,  A61P1/00 ,  A61K35/745 ,  A61K45/06

CPC classification number: A23L33/135 ,  A61K35/745 ,  A61K45/06 ,  A61P1/00

Abstract: The present invention relates to Bifidobacterium breve deposited as DSM 32356 and compositions comprising said strain. The composition may further comprise at least one other bacterial strain and/or at least one compound which may be an NSAID such as acetylsalicylic acid (aspirin). In a presently preferred embodiment the invention relates to Bifidobacterium breve deposited as DSM 32356 for use in the support of the defense against intestinal tissue damage such as intestinal mucosal breaks or lesions e.g. in connection with NSAID administration such as in connection with administration of acetylsalicylic acid (aspirin). The invention further provides a method of supporting the defense against intestinal tissue damage, the method comprising administering the Bifidobacterium breve strain deposited as DSM 32356 to a subject in need thereof, e.g. to a subject in need of NSAID treatment.